We serve Chemical Name:(3-Amino-4-chlorophenyl)boronic acid CAS:850689-36-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(3-Amino-4-chlorophenyl)boronic acid
CAS.NO:850689-36-0
Synonyms:3-amino-4-chlorophenylboronic acid;(3-Amino-4-chlorophenyl)boronic acid;Boronic acid, B-(3-amino-4-chlorophenyl)-
Molecular Formula:C6H7BClNO2
Molecular Weight:171.389
HS Code:2931900090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:372.9±52.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.602
PSA:66.48000
Exact Mass:171.025833
LogP:1.28
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-amino-4-chlorophenylboronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Boronic acid, B-(3-amino-4-chlorophenyl)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3-Amino-4-chlorophenyl)boronic acid Use and application,Boronic acid, B-(3-amino-4-chlorophenyl)- technical grade,usp/ep/jp grade.
Related News: The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful. (3-Amino-4-chlorophenyl)boronic acid manufacturer Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients. (3-Amino-4-chlorophenyl)boronic acid supplier The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills. (3-Amino-4-chlorophenyl)boronic acid vendor The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful. (3-Amino-4-chlorophenyl)boronic acid factory The monthly injection to suppress the virus that causes AIDS was aimed as an alternative to daily pills.
